Financial Statements
- Click here to download Vertex Pharmaceuticals, Inc.'s Income Statement
- Click here to download Vertex Pharmaceuticals, Inc.'s Balance Sheet
- Click here to download Vertex Pharmaceuticals, Inc.'s Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: Reshma Kewalramani
Key Statistics
- Stock Price: $214.89
- Dividend Yield: 0%
- Market Capitalization: $55,368,893,605
- Shares Outstanding: 259,960,062
- Number of Employees: 0
- Trailing 12-Month EPS: $10.29
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2021-04-29
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $214.89
- 52-week high: $306.08
- 52-week low: $202.57
- 200-day moving average: $228.76
- 50-day moving average: $213.55
Performance
- 1-Month Price Return: 0.2%
- 3-Month Price Return: -8.5%
- 6-Month Price Return: -21.2%
- 1-Year Price Return: -8.2%
- 2-Year Price Return: 15.8%
- 5-Year Price Return: 171.7%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast